Choice Hotels Scraps Roughly $7 Billion Bid For Wyndham After Rebuff
Choice Hotels said it is abandoning its roughly $7 billion takeover bid for rival Wyndham Hotels & Resorts after attempting to drive a deal through despite being rebuffed by Wyndham's board.
Reddit Aims for IPO Valuation of Up to $6.4B
The social-media company said it plans to issue 22 million shares of its class A common stock at a price of $31 to $34 a share.
EQT and Equitrans Midstream to Combine in Big Natural-Gas Deal
The all-stock transaction will reunite EQT with its former pipeline business.
Elon Musk's xAI to Open-Source Its Grok Chatbot, in Latest Swipe at OpenAI
The move will be seen as another salvo in the long-simmering feud between Musk and OpenAI's Chief Executive Sam Altman in the artificial-intelligence arms race.
Behind the Alaska Blowout: a Manufacturing Habit Boeing Can't Break
Snafus in production means work gets completed out of sequence. "It creates opportunities for failure."
Dongfeng Motor Shares Slump After Profit Warning
Dongfeng Motor's shares slumped after the Chinese automaker said it expects to swing to loss for 2023 amid intensifying competition.
CATL Shares Rise After JV News, Morgan Stanley Upgrade
Contemporary Amperex Technology's shares surged Monday on multiple drivers, including news of a collaboration with Chinese companies Xiaomi and BAIC Motor, as well as an upgrade by Morgan Stanley.
Apple to Open New Store in Shanghai Amid Falling iPhone Sales
Apple is preparing to open its eighth store in Shanghai this month amid slipping iPhone sales in the world's largest smartphone market.
Nvidia's Supercharged Investment Strategy Is About More Than Returns
The chip maker more than tripled its investments last year as the company seeks to stay ahead of AI developments.
Wall Street Predicted a Blockbuster. Now the Drug May Be Withdrawn.
Amylyx's ALS drug failed a late-stage trial, raising questions about the future of the drug and the company itself.
(END) Dow Jones Newswires
03-11-24 0715ET